Best TWAS P=1.13e-11 · Best GWAS P=4.52e-20 conditioned to 1.19e-06
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Heart Atrial Appendage | PROS1 | 0.31 | 0.16 | enet | 7 | 0.19 | 8.4e-09 | 6.6 | -6.3 | 2.8e-10 | -0.68 | 0.95 | 0.02 | FALSE |
2 | METSIM | Adipose | STX19 | 0.06 | 0.09 | lasso | 3 | 0.08 | 1.8e-11 | 5.9 | 6.4 | 1.4e-10 | 0.50 | 1.00 | 0.00 | FALSE |
3 | YFS | Blood | DHFRL1 | 0.07 | 0.04 | lasso | 9 | 0.04 | 4.1e-14 | 7.1 | 6.8 | 1.1e-11 | 0.54 | 1.00 | 0.00 | TRUE |
4 | The Cancer Genome Atlas | Breast Invasive Carcinoma | DHFRL1 | 0.07 | 0.05 | lasso | 1 | 0.05 | 3.4e-11 | 5.9 | -5.9 | 3.6e-09 | -0.43 | 0.26 | 0.74 | FALSE |
5 | The Cancer Genome Atlas | Breast Invasive Carcinoma | STX19 | 0.04 | 0.02 | lasso | 1 | 0.01 | 5.5e-04 | 6.6 | 6.6 | 4.9e-11 | 0.64 | 0.01 | 0.91 | FALSE |
6 | The Cancer Genome Atlas | Glioblastoma Multiforme | DHFRL1 | 0.20 | 0.12 | lasso | 8 | 0.11 | 3.7e-04 | 5.9 | -5.9 | 2.7e-09 | -0.44 | 0.01 | 0.11 | FALSE |
7 | The Cancer Genome Atlas | Glioblastoma Multiforme | STX19 | 0.52 | -0.01 | enet | 15 | 0.17 | 5.6e-06 | 6.6 | 5.4 | 8.5e-08 | 0.30 | 0.00 | 0.18 | FALSE |
8 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | DHFRL1 | 0.07 | 0.05 | enet | 17 | 0.05 | 2.5e-06 | 5.9 | -6.5 | 7.3e-11 | -0.54 | 0.04 | 0.92 | FALSE |
9 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | DHFRL1 | 0.13 | 0.07 | lasso | 2 | 0.07 | 5.7e-08 | 5.9 | -5.9 | 3.6e-09 | -0.43 | 0.25 | 0.75 | FALSE |
10 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | STX19 | 0.35 | 0.11 | enet | 12 | 0.20 | 2.4e-22 | 6.6 | 6.5 | 1.0e-10 | 0.49 | 0.01 | 0.99 | FALSE |
11 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | STX19 | 0.60 | 0.12 | enet | 25 | 0.36 | 2.4e-21 | 6.6 | 5.3 | 1.5e-07 | 0.33 | 0.01 | 0.99 | FALSE |
12 | The Cancer Genome Atlas | Brain Lower Grade Glioma | DHFRL1 | 0.10 | 0.06 | lasso | 2 | 0.05 | 5.2e-06 | 5.9 | -5.9 | 3.6e-09 | -0.43 | 0.25 | 0.74 | FALSE |
13 | The Cancer Genome Atlas | Brain Lower Grade Glioma | STX19 | 0.51 | 0.13 | enet | 19 | 0.34 | 3.9e-40 | 6.6 | 5.7 | 1.4e-08 | 0.40 | 0.01 | 0.99 | FALSE |
14 | The Cancer Genome Atlas | Liver Hepatocellular Carcinoma | STX19 | 0.15 | 0.08 | lasso | 1 | 0.05 | 1.8e-03 | 6.6 | 6.6 | 4.9e-11 | 0.64 | 0.01 | 0.85 | FALSE |
15 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | STX19 | 0.28 | -0.01 | enet | 15 | 0.08 | 6.4e-04 | 6.6 | 5.9 | 3.3e-09 | 0.44 | 0.00 | 0.30 | FALSE |
16 | The Cancer Genome Atlas | Thyroid Carcinoma | ARL13B | 0.03 | 0.00 | blup | 39 | 0.00 | 2.1e-01 | -6.6 | 6.6 | 3.6e-11 | 0.66 | 0.01 | 0.67 | TRUE |
17 | The Cancer Genome Atlas | Thyroid Carcinoma | STX19 | 0.24 | 0.03 | enet | 10 | 0.09 | 2.4e-09 | 6.6 | 5.5 | 4.5e-08 | 0.36 | 0.00 | 0.66 | FALSE |